Across TCGA pan-cancer cohorts, LINC00392 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC00392’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC00392 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00392 is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

HNSC, LUSC, and BRCA are the cancer types where LINC00392 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00392 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+1.006	.002	11	view →
LUSC	All	All	+1.272	<.001	5	view →
BRCA	Female	All	+0.213	.023	4	view →
BLCA	Male	All	+0.608	.003	3	view →
STAD	All	All	+0.983	.022	2	view →
PRAD	All	All	−0.124	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

Exploration

Same gene, other analysis: LINC00392 RNA expression & survival · all LINC00392 data types